Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment-Reference-Cited by-同舟云学术

Molecular classification of endometrial carcinoma on diagnostic specimens is highly concordant with final hysterectomy: Earlier prognostic information to guide treatment

Published:2016-10 Issue:1 Volume:143 Page:46-53
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Talhouk Aline,Hoang Lien N.,McConechy Melissa K.,Nakonechny Quentin,Leo Joyce,Cheng Angela,Leung Samuel,Yang Winnie,Lum Amy,Köbel Martin,Lee Cheng-Han,Soslow Robert A.,Huntsman David G.,Gilks C. Blake,McAlpine Jessica N.^ORCID

Funder

Canadian Institute of Health Research

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. Global burden of cancer attributable to high body-mass index in 2012: a population-based study;Arnold;Lancet Oncol.,2015

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

3. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States;Rahib;Cancer Res.,2014

4. Prediction of cancer incidence and mortality in Korea, 2014;Jung;Cancer Res. Treat.,2014

5. Histotype-genotype correlation in 36 high-grade endometrial carcinomas;Hoang;Am. J. Surg. Pathol.,2013

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma;Gynecologic Oncology;2024-11

2. Advanced endometrial cancer—The next generation of treatment: A society of gynecologic oncology journal club clinical commentary;Gynecologic Oncology Reports;2024-10

3. Molecular classification improves preoperative risk assessment of endometrial cancer;Gynecologic Oncology;2024-10

4. The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup;Gynecologic Oncology;2024-10

5. Correspondence on ‘Predicting the risk of nodal disease with histological and molecular features in endometrial cancer: the prospective PROME trial’ by Bogani et al;International Journal of Gynecologic Cancer;2024-09-07